Clinical Trials Browser

Phase 2 × Multiple Myeloma × Sugars × Clear all

NCT02440464 2023-01-04

Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)

Phase 2 Completed

57 enrolled 22 charts

Hematologic Diseases, Multiple Myeloma

NCT01793051 2021-11-24

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

Phase 2 Completed

88 enrolled 6 charts

cyclopia sequence, Multiple Myeloma, Neoplasms, Plasma Cell